Accelerating antibody discovery with cell-free DNA synthesis
Advances in synthetic biology and automation accelerate high throughput antibody screening.
Antibody Discovery
Overcoming a key bottleneck in antibody development
Researchers embrace automation to speed up antibody purification for accelerated therapeutic breakthroughs.
Driving Therapeutic Antibody Discovery with Artificial Intelligence
Learn how scientists integrate computational biology and experimental data to accelerate antibody drug development.
Accelerating the Discovery and Development of Antibody Therapeutics
LIVE May 20th, 2021 at 2:30 PM ET
In this webinar, Berkeley Lights scientists present a new platform for antibody discovery and cell line development that accelerates the identification and production of leading therapeutic molecules.
In this webinar, Berkeley Lights scientists present a new platform for antibody discovery and cell line development that accelerates the identification and production of leading therapeutic molecules.
Novel SARS-CoV-2 neutralizing antibodies
Therapeutic candidates retain binding to major COVID-19-causing “South African” variant
DNN Webinar: Accelerating Patient-Derived Antibody Discovery and Optimization
Although antibody-based immunotherapies have greatly facilitated precision medicine in cancer, the increasingly smaller patient populations and challenging manufacture make them an expensive proposition. This webinar will highlight new approaches for accelerating antibody discovery and optimization.
